API Patent Litigation: Expert Consultant
Crystallization & Precipitation Processes: Specialist-Expert-Consultant
Speaker: Delivering Worldwide 1 or 2-day Crystallization and Polymorphism Workshops
Litigation support: API polymorphism expert, API salt/cocrystal expert, crystallization process expert
A highly accomplished scholar, scientist, and inventor with over 40 years of balanced international experience in both academic and industrial research on crystallization and precipitation processes.
linkedin.com/in/peter-h-karpinski-ph-d-d-sc-887a6988
EXPERT CONSULTING SERVICES
2021 Inductee of the ‘Heroes of Chemistry’, a scientific hall of fame of the American Chemical Society (ACS)
Recognized for innovations in medicine for ENTRESTO® (sacubitril/valsartan)
Consultant, expert witness, and speaker in the areas of polymorphism, salt selection, and properties of APIs; and crystallization & precipitation processes
-
As an academic, for combined 15 years, taught chemical engineering at Wroclaw University of Science and Technology (Poland), Iowa State University (US), and Worcester Polytechnic Institute (US).
-
As a scientist at Eastman Kodak Company for 14 years, engineered new submicron-sized AgX crystalline forms and pioneered development of nanosized pharmaceutical crystals for Sterling Winthrop.
-
In his 14 years at Novartis, had concurrently been a leader of both Salt & Polymorphism and Particle Engineering networks. Responsibilities included salt, cocrystal, and polymorphic form selection for API development; API property characterization, crystal and particle engineering, and optimization and scale up of API crystallization processes. Supervised over 280 API projects dealing with salt/cocrystal and polymorph screening, form selection, and crystallization development. Investigated >850 polymorphs and solvatomorphs (hydrates and solvates).
-
Authored/co-authored two monographs, ten book chapters, 28 patents, >40 refereed papers, and >100 papers presented.
-
Just two APIs he co-invented and led their early development: Tasigna® and Entresto®, currently bring over $6 billion annually in revenue.
Ranked high among polymorphism experts